AMIX vs. NSPR, ICCM, APYX, CTSO, MGRM, SEPA, LUCD, DRIO, DXR, and PDEX
Should you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include InspireMD (NSPR), IceCure Medical (ICCM), Apyx Medical (APYX), Cytosorbents (CTSO), Monogram Orthopaedics (MGRM), SEP Acquisition (SEPA), Lucid Diagnostics (LUCD), DarioHealth (DRIO), Daxor (DXR), and Pro-Dex (PDEX). These companies are all part of the "surgical & medical instruments" industry.
Autonomix Medical (NASDAQ:AMIX) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.
10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 29.7% of InspireMD shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Autonomix Medical has a net margin of 0.00% compared to InspireMD's net margin of -350.35%. Autonomix Medical's return on equity of 0.00% beat InspireMD's return on equity.
InspireMD has a consensus target price of $4.85, suggesting a potential upside of 110.87%. Given InspireMD's higher possible upside, analysts clearly believe InspireMD is more favorable than Autonomix Medical.
Autonomix Medical has higher earnings, but lower revenue than InspireMD.
InspireMD received 2 more outperform votes than Autonomix Medical when rated by MarketBeat users.
In the previous week, InspireMD had 4 more articles in the media than Autonomix Medical. MarketBeat recorded 6 mentions for InspireMD and 2 mentions for Autonomix Medical. Autonomix Medical's average media sentiment score of 0.93 beat InspireMD's score of -0.76 indicating that Autonomix Medical is being referred to more favorably in the media.
Summary
InspireMD beats Autonomix Medical on 7 of the 12 factors compared between the two stocks.
Get Autonomix Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Autonomix Medical Competitors List
Related Companies and Tools
